Folbe Adam, Herzallah Islam, Duvvuri Umamaheswar, Bublik Michael, Sargi Zoukaa, Snyderman Carl H, Carrau Ricardo, Casiano Roy, Kassam Amin Bardai, Morcos Jacques J
Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Am J Rhinol Allergy. 2009 Jan-Feb;23(1):91-4. doi: 10.2500/ajra.2009.23.3269.
BACKGROUND: This study reports the combined experience of the University of Miami and University of Pittsburgh with endoscopic endonasal resection of esthesioneuroblastoma (ENB). A retrospective case series review was performed in a tertiary care university hospital. METHODS: Twenty-three patients, 16 men and 7 women, were reviewed. Mean age was 56.6 years (15-79 years). Nineteen patients received primary endoscopic endonasal anterior skull base resection. Of these, the modified Kadish stage at presentation was A in 2 patients, B in 11 patients, C in 5 patients, and D in 1 patient. Three patients had revision surgeries for recurrent tumors. The main outcome measures were complete resection and margin assessment, short-term and long-term complications, and recurrence rate. RESULTS: Complete resection and negative intraoperative resection margins were achieved endoscopically in 17 of the primarily treated cases. The two other cases had one patient that required an additional craniotomy approach to complete the resection of a positive lateral dual margin, another patient had positive margins at the orbital apex. All patients tolerated the endoscopic procedure very well with no meningitis. There were four cerebral spinal fluid leaks. Mean follow-up period for the primarily treated cases was 45.2 months (11-152 months), all were disease free at the most recent available follow-up. CONCLUSION: In experienced hands and carefully selected patients, endoscopic resection of ENB respects the principles of oncologic surgery, providing an adequate exposure for margin assessment as well as reliable reconstruction of the anterior skull defect with a relatively low morbidity.
背景:本研究报告了迈阿密大学和匹兹堡大学在内镜经鼻切除嗅神经母细胞瘤(ENB)方面的综合经验。在一家三级医疗大学医院进行了回顾性病例系列研究。 方法:对23例患者进行了回顾,其中男性16例,女性7例。平均年龄为56.6岁(15 - 79岁)。19例患者接受了初次内镜经鼻前颅底切除术。其中,初诊时改良Kadish分期为A期2例,B期11例,C期5例,D期1例。3例患者因肿瘤复发接受了二次手术。主要观察指标为完全切除、切缘评估、短期和长期并发症以及复发率。 结果:在19例初次治疗的病例中,17例通过内镜实现了完全切除且术中切缘阴性。另外2例中,1例患者需要额外的开颅手术来完成外侧双切缘阳性肿瘤的切除,另1例患者眶尖切缘阳性。所有患者对内镜手术耐受性良好,无脑膜炎发生。有4例脑脊液漏。初次治疗病例的平均随访期为45.2个月(11 - 152个月),在最近一次随访时所有患者均无疾病复发。 结论:在内镜技术熟练的医生手中,对于精心挑选的患者,内镜切除ENB符合肿瘤外科手术原则,能提供足够的视野进行切缘评估,并能可靠地重建前颅底缺损,且发病率相对较低。
Am J Rhinol Allergy. 2009
Am J Otolaryngol. 2010-8-21
J Clin Neurosci. 2012-9-18
Am J Rhinol. 2001
Acta Otolaryngol. 2014-12
Laryngoscope. 2003-12
Clin Neurol Neurosurg. 2015-11
Ann Med Surg (Lond). 2025-1-21
Virchows Arch. 2024-4
J Neurol Surg B Skull Base. 2021-7